124 related articles for article (PubMed ID: 6749737)
1. Dopamine receptors in the central nervous system.
Creese I; Morrow AL; Leff SE; Sibley DR; Hamblin MW
Int Rev Neurobiol; 1982; 23():255-301. PubMed ID: 6749737
[No Abstract] [Full Text] [Related]
2. The classification of dopamine receptors: relationship to radioligand binding.
Creese I; Sibley DR; Hamblin MW; Leff SE
Annu Rev Neurosci; 1983; 6():43-71. PubMed ID: 6220666
[No Abstract] [Full Text] [Related]
3. Auto- and postsynaptic dopamine receptors in the central nervous system.
Rebec GV
Monogr Neural Sci; 1984; 10():207-23. PubMed ID: 6321971
[No Abstract] [Full Text] [Related]
4. Dopamine receptors in the central nervous system.
Creese I; Sibley DR; Hamblin MW; Leff SE
Adv Biochem Psychopharmacol; 1983; 36():125-34. PubMed ID: 6344562
[No Abstract] [Full Text] [Related]
5. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
[No Abstract] [Full Text] [Related]
6. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
Neve KA; Altar CA; Wong CA; Marshall JF
Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
[TBL] [Abstract][Full Text] [Related]
7. Structure activity relationships of presynaptic dopamine receptor agonists.
Bhatnagar RK; Arnerić SP; Cannon JG; Flynn J; Long JP
Pharmacol Biochem Behav; 1982; 17 Suppl 1():11-9. PubMed ID: 7184032
[TBL] [Abstract][Full Text] [Related]
8. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
Hall MD; Jenner P; Kelly E; Marsden CD
Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
[TBL] [Abstract][Full Text] [Related]
9. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
10. The relative importance of dopamine and norepinephrine in mediating locomotor activity.
Fishman RH; Feigenbaum JJ; Yanai J; Klawans HL
Prog Neurobiol; 1983; 20(1-2):55-88. PubMed ID: 6141594
[No Abstract] [Full Text] [Related]
11. Control of dopamine release by dopamine receptors and by impulse flow as studied by in vivo voltammetry.
Gonon FG
Ann N Y Acad Sci; 1986; 473():160-9. PubMed ID: 3492168
[No Abstract] [Full Text] [Related]
12. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
Cross AJ; Waddington JL
Eur J Pharmacol; 1981 May; 71(2-3):327-32. PubMed ID: 7250192
[TBL] [Abstract][Full Text] [Related]
13. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
14. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
Titeler M
Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
[No Abstract] [Full Text] [Related]
15. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
[No Abstract] [Full Text] [Related]
16. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
Creese I; Snyder SH
Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
[TBL] [Abstract][Full Text] [Related]
17. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
Quik M; Emson PC; Joyce E
Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
[TBL] [Abstract][Full Text] [Related]
18. Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist.
Hanson G; Alphs L; Pradhan S; Lovenberg W
Neuropharmacology; 1981 Jun; 20(6):541-8. PubMed ID: 6165922
[No Abstract] [Full Text] [Related]
19. Irreversible interaction of beta-haloalkylamine derivatives with dopamine D1 and D2 receptors.
Cross AJ; Waddington JL; Ross ST
Life Sci; 1983 Jun; 32(24):2733-40. PubMed ID: 6222234
[TBL] [Abstract][Full Text] [Related]
20. Fetal substantia nigra grafts. Effect on dopamine receptors in the rat corpus striatium.
Korfali E; Knowles WD; Uysal S; Ulus IH; Ozmen T
Cleve Clin J Med; 1989 May; 56(3):259-62. PubMed ID: 2568188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
